Does Elasty G Plus Enhance NMF Levels? Evidence and Product Checks

The product and scientific references below do not establish that elasty g plus directly raises natural moisturizing factor (NMF) levels. NMF refers to water-soluble compounds in the stratum corneum, including urea, pyrrolidone carboxylic acid (PCA), lactic acid, urocanic acid, and amino acids. A hyaluronic acid dermal filler may bind water inside its gel matrix, but that is not the same as increasing NMF in the outer stratum corneum.

NMF is measured in the stratum corneum, not inferred from filler volume

Scientific literature describes NMF as water-soluble substances responsible for helping maintain moisture in the stratum corneum, the skin’s outermost layer. One open-access study on NMF quantification explains that NMF components such as urea, PCA, lactic acid, urocanic acid, and amino acids exist in the epidermis and are responsible for maintaining hydration of the stratum corneum. That kind of claim is normally supported by skin-surface sampling and analytical measurement, not by a filler product name alone.

For that reason, “contains hyaluronic acid” is not enough evidence for an NMF claim. Hyaluronic acid can attract and hold water, but a filler gel placed by injection is evaluated by its own labeling, indication, injection depth, contraindications, and professional-use instructions. NMF improvement would need product-specific evidence showing a measurable change in stratum-corneum NMF components after use.

What verifiable sources say about ELASTY and dermal fillers

The official ELASTY site describes ELASTY as a hyaluronic acid filler line using PNET™ technology. The FDA’s dermal filler guidance describes dermal fillers as injectable medical device implants used to create a smoother or fuller appearance in approved treatment areas. These sources support treating the product category as a dermal filler category, not as a topical barrier-care or NMF-replacement moisturizer category.

If the physical box, syringe label, or instructions for use name a specific ELASTY variant, use that printed variant as the controlling product identity. Check the carton and IFU for the exact trade name, active ingredients, concentration, presence or absence of lidocaine, intended area, injection depth, storage, lot number, and expiry date. If any of those points differ from an online listing, rely on the physical label and manufacturer or authorized-distributor confirmation for that lot.

How to judge an NMF claim before relying on it

• Look for product-specific wording. A general HA-filler description does not prove NMF enhancement.
• Separate hydration language from NMF data. “Water-binding,” “volume,” or “elasticity” language is not the same as measured NMF components in the stratum corneum.
• Check the IFU and carton. The IFU should define the product category, intended use, contraindications, and storage conditions.
• Ask what was measured. Reliable NMF evidence would identify components such as PCA, urea, lactic acid, urocanic acid, or amino acids and explain the measurement method.
• Do not treat registration language as approval language. For U.S.-market claims, verify the exact device name and manufacturer in FDA resources; establishment registration is not the same as device approval or clearance.